Impact of diet change on the gut microbiome of common marmosets ( Callithrix jacchus )

Appropriate diet and health of the common marmoset in captivity are essential both for the welfare of the animal and to improve experimental outcomes. Our study shows that a gel diet compared to a biscuit diet improves the health of a marmoset colony, is linked to increases in Bifidobacterium specie...

Full description

Saved in:
Bibliographic Details
Published inmSystems Vol. 9; no. 8; p. e0010824
Main Authors Tang-Wing, Cassandra, Mohanty, Ipsita, Bryant, MacKenzie, Makowski, Katherine, Melendez, Daira, Dorrestein, Pieter C., Knight, Rob, Caraballo-Rodríguez, Andrés Mauricio, Allaband, Celeste, Jenné, Keith
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 20.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Appropriate diet and health of the common marmoset in captivity are essential both for the welfare of the animal and to improve experimental outcomes. Our study shows that a gel diet compared to a biscuit diet improves the health of a marmoset colony, is linked to increases in Bifidobacterium species, and increases the removal of molecules associated with disease. The diet transition had an influence on the molecular changes at both the pair and time point group levels, but only at the pair level for the microbial changes. It appears to be more important which genes and functions present changed rather than specific microbes. Further studies are needed to identify specific components that should be considered when choosing an appropriate diet and additional supplementary foods, as well as to validate the benefits of providing probiotics. Probiotics containing Bifidobacterium species appear to be useful as probiotic supplements to the laboratory marmoset diet, but additional work is needed to validate these findings.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
P.C.D. is an advisor and holds equity in Sirenas and Cybele, consulted for MSD animal health in 2023, and is a co-founder and scientific advisor and holds equity in Ometa Labs, Arome, and Enveda with prior approval by UC San Diego. R.K. declares the following: Gencirq, stock and SAB member; DayTwo, consultant and SAB member; Cybele, stock and consultant; Biomesense, stock, consultant, and SAB member; Micronoma, stock, SAB member, and co-founder; and Biota, stock and co-founder.
ISSN:2379-5077
2379-5077
DOI:10.1128/msystems.00108-24